Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017739.4(POMGNT1):c.187C>T(p.Arg63*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
POMGNT1 (HGNC:19139): (protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)) This gene encodes a type II transmembrane protein that resides in the Golgi apparatus. It participates in O-mannosyl glycosylation and is specific for alpha linked terminal mannose. Mutations in this gene may be associated with muscle-eye-brain disease and several congenital muscular dystrophies. Alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Feb 2014]
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-46197018-G-A is Pathogenic according to our data. Variant chr1-46197018-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 3994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-46197018-G-A is described in Lovd as [Pathogenic]. Variant chr1-46197018-G-A is described in Lovd as [Likely_pathogenic]. Variant chr1-46197018-G-A is described in Lovd as [Pathogenic].
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
-
- -
Likely pathogenic, no assertion criteria provided
clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
-
- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 Pathogenic:2
Pathogenic, no assertion criteria provided
literature only
OMIM
May 26, 2009
- -
Pathogenic, criteria provided, single submitter
clinical testing
Baylor Genetics
Mar 14, 2023
- -
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;C3150417:Autosomal recessive limb-girdle muscular dystrophy type 2O;C3151519:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;C4310704:Retinitis pigmentosa 76 Pathogenic:1
Pathogenic, criteria provided, single submitter
clinical testing
Fulgent Genetics, Fulgent Genetics
Mar 21, 2024
- -
Retinitis pigmentosa 76 Pathogenic:1
Pathogenic, no assertion criteria provided
literature only
OMIM
Sep 20, 2016
- -
Autosomal recessive limb-girdle muscular dystrophy type 2O Pathogenic:1
Pathogenic, criteria provided, single submitter
curation
Laboratory of Medical Genetics, National & Kapodistrian University of Athens
Feb 01, 2024
- -
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;C3150417:Autosomal recessive limb-girdle muscular dystrophy type 2O Pathogenic:1
Pathogenic, criteria provided, single submitter
clinical testing
Labcorp Genetics (formerly Invitae), Labcorp
Feb 18, 2023
This sequence change creates a premature translational stop signal (p.Arg63*) in the POMGNT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POMGNT1 are known to be pathogenic (PMID: 19299310, 20816175, 21447391, 26908613, 27391550). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with muscle-eye-brain disease (PMID: 12588800, 26908613). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3994). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. -